-transparent.png){kind=logo}
In order to find an effective and suitable chemotherapy regimen for preoperative treatment of esophageal cancer, patients with inoperable or metastatic disease were treated with a combination of etoposide and cisplatin. Of 27 evaluable patients, 13 had squamous cell carcinoma, 13 adenocarcinoma, and 1 muco-epidermoid carcinoma. No complete responses were noted. Nine of 13 patients with squamous cell carcinoma and only one of 13 with adenocarcinoma showed a partial response. Nine of 10 responders achieved a partial response after 2 courses, one after 4 courses. There was one toxic death, due to sepsis during leukopenia. Other toxicities were alopecia, nausea and vomiting, nephrotoxicity, thrombocytopenia and leukopenia.
T C Kok, and
T A Splinter, and
J Verweij
February 1987,
American journal of clinical oncology,
T C Kok, and
T A Splinter, and
J Verweij
April 1990,
Seminars in oncology,
T C Kok, and
T A Splinter, and
J Verweij
April 1988,
Tumori,
T C Kok, and
T A Splinter, and
J Verweij
December 1997,
Seminars in oncology,
T C Kok, and
T A Splinter, and
J Verweij
June 1994,
Journal of chemotherapy (Florence, Italy),
T C Kok, and
T A Splinter, and
J Verweij
January 1991,
European journal of cancer (Oxford, England : 1990),
T C Kok, and
T A Splinter, and
J Verweij
October 1991,
Annals of oncology : official journal of the European Society for Medical Oncology,
T C Kok, and
T A Splinter, and
J Verweij
February 1990,
Gan to kagaku ryoho. Cancer & chemotherapy,
T C Kok, and
T A Splinter, and
J Verweij
January 1994,
European journal of cancer (Oxford, England : 1990),
T C Kok, and
T A Splinter, and
J Verweij
November 1996,
Cancer,
